Metformin and Gut Side Effects: What Helps

Metformin stomach side effects — nausea, diarrhoea, bloating, cramping and wind — are the most common reason people stop taking the UK's most widely prescribed diabetes medicine. The reassuring news is that these symptoms are largely predictable, usually temporary, and often fixable without abandoning treatment. This guide explains why metformin irritates the digestive tract, what the evidence says genuinely helps, and how to protect your gut health while staying on therapy.

Start here: gut health in the UK · probiotics · Akkermansia muciniphila · citrus pectin powder · Welzo Ultra Purity Berberine · Welzo Ultra Purity TUDCA · gut dysbiosis · Bristol stool chart · best probiotics UK · berberine vs metformin

Written and medically reviewed by Dr Zeeshan Afzal, MBBS — Medical Officer, Welzo. Last reviewed: August 2026.

Important: this article is health information, not personal medical advice. Metformin is a prescription medicine that protects you from the long-term complications of diabetes. Never stop it, reduce it, or change the formulation without speaking to your GP, diabetes nurse or pharmacist first.

Table of contents

• Metformin stomach side effects at a glance
• Why metformin upsets the stomach: five mechanisms
• How long do metformin stomach side effects last?
• What actually helps: the evidence-based playbook
• Metformin and the gut microbiome
• Vitamin B12: the side effect people miss
• When it isn't the metformin
• Red flags: when to contact a GP or NHS 111
• A practical four-week plan
• Frequently asked questions
• References

Metformin stomach side effects at a glance

Metformin's digestive side effects are listed as "very common" in its product information, meaning they affect more than 1 in 10 people. Older clinical estimates suggest gastrointestinal symptoms affect roughly 20–30% of people starting metformin, with around 5% unable to tolerate the drug at all.

A 2024 systematic review and meta-analysis published in BMC Endocrine Disorders, pooling 21 observational studies and 25,206 people with type 2 diabetes, produced the most reliable real-world figures we currently have. Diarrhoea was the most frequent complaint, and it appeared in every single study analysed.

If you are unsure whether your stools have genuinely changed or you are simply more aware of them, the Bristol stool chart is a useful objective reference to track before and after any change you make.

Why metformin upsets the stomach: five mechanisms

Understanding the mechanism matters, because each one points to a different fix. Metformin is unusual among diabetes drugs in that much of its glucose-lowering action happens inside the gut itself rather than in the bloodstream. Concentrations of metformin in the intestinal wall can be far higher than in plasma — which is exactly why the gut bears the brunt.

1. High drug concentration in the intestinal wall

Metformin is actively transported into gut cells by organic cation transporters, particularly OCT1 (encoded by SLC22A1). Genetic variation in these transporters changes how much drug accumulates locally — which is one reason two people on identical doses can have completely different experiences. The landmark GoDARTS study found that people carrying reduced-function OCT1 variants were substantially more likely to be intolerant of metformin.

2. Serotonin release from the duodenum

Metformin is structurally related to compounds that act on serotonin (5-HT3) pathways, and laboratory work has shown it triggers serotonin release from human duodenal mucosa. Serotonin is the same signalling molecule involved in chemotherapy-induced nausea, which helps explain why early metformin nausea can feel disproportionate to the dose. The gut–brain connection is not a metaphor here — it is the mechanism.

3. Reduced bile salt reabsorption

Normally around 95% of bile acids are reclaimed in the terminal ileum. Metformin reduces this reabsorption, so more bile acid reaches the colon, where it stimulates fluid secretion and motility. This is the same physiology that underlies bile acid malabsorption, and it explains the characteristic urgent, yellow, loose stool some people describe. If you are interested in bile acid biology more broadly, our guide to TUDCA and its side effect profile covers the wider picture — though TUDCA is not a treatment for metformin-related diarrhoea and should not be started without advice.

4. Osmotic load in the colon

Metformin increases intestinal glucose uptake and lactate production, and undigested substrate arriving in the colon draws water in osmotically. This produces the loose, sometimes explosive stools most typical of the first two weeks.

5. Microbiome shifts

Metformin measurably reshapes the gut microbiota. Landmark work published in Nature and Nature Medicine showed consistent increases in Escherichia and Akkermansia muciniphila and reductions in Intestinibacter. Crucially, a study in healthy volunteers found that the severity of gastrointestinal side effects tracked with the rise in Escherichia–Shigella — a marker of transient gut dysbiosis. Some of these changes are believed to contribute to metformin's benefits, so the goal is not to block them but to buffer the turbulence while the ecosystem re-equilibrates. Broader microbiome diversity and healthy short-chain fatty acid production appear to make that transition smoother.

How long do metformin stomach side effects last?

For most people, the answer is two to four weeks. Symptoms cluster around initiation and around every dose increase, then settle as the gut adapts. Discontinuations, when they happen, overwhelmingly occur early in treatment.

Symptoms that begin months or years after a stable dose are a different story. A 2024 case report in Cureus described a patient whose metformin-induced chronic diarrhoea was misdiagnosed as irritable bowel syndrome for six years, with 6 kg of weight loss, before the drug was identified as the cause. Late-onset diarrhoea in someone on long-term metformin deserves proper investigation rather than assumption — see our guide on IBS types and when to see a GP about stomach symptoms.

What actually helps: the evidence-based playbook

These are ordered by strength of evidence and ease of implementation. The first four are the ones your GP or diabetes nurse is most likely to recommend.

Take it with or immediately after food

This is the single highest-yield change and it costs nothing. The NHS medicines guidance is explicit: taking metformin with food reduces the chance of feeling sick. A substantial meal — not a biscuit — slows gastric emptying and dilutes the local drug concentration hitting the intestinal lining. If you are taking a twice-daily dose, anchor it to your two largest meals.

Start low and increase slowly

NICE guidance advises gradually increasing the dose over several weeks specifically to minimise gastrointestinal side effects. If you have been titrated up quickly and are struggling, ask whether the increase can be stretched out. Interestingly, the 2024 meta-analysis found no clear relationship between total dose and symptom rate — suggesting the speed of escalation matters more than the final number.

Switch to modified-release metformin

This is the most important practical development in this area. In February 2026, NICE updated guideline NG28 to recommend modified-release metformin as the first-choice formulation for adults with type 2 diabetes, rather than reserving it for people who fail on standard-release. The committee's reasoning: modified-release has similar effectiveness on HbA1c and weight, similar hypoglycaemia safety, is associated with reductions in gastrointestinal adverse events, is likely to be better adhered to, and in December 2025 cost less than standard-release.

The 2024 meta-analysis supports this, finding statistically lower rates of bloating, abdominal pain, constipation and vomiting with extended-release formulations. If you are on standard-release and tolerating it well, there is no need to switch. If you are not, this is the conversation to have.

Review your other medicines

The GoDARTS study found that taking medicines which inhibit OCT1 alongside metformin was significantly associated with intolerance. Verapamil increased the odds of intolerance around sevenfold; proton pump inhibitors, citalopram, doxazosin and codeine were also implicated. Proton pump inhibitors deserve particular attention because they also compound the B12 problem — see our guide to the long-term effects of omeprazole. Iron tablets and some antidepressants independently cause bowel changes, covered in our guides to iron supplements and constipation and antidepressants and constipation. Take a full list to your pharmacist for a medicines review — it is free on the NHS.

Adjust what you eat around the dose

Metformin symptoms and everyday digestive triggers stack. While you are adapting, it is worth temporarily reducing the load from foods that commonly cause bloating, very high-fat meals, alcohol and large quantities of sugar alcohols. Some people find a short, structured trial of the low FODMAP diet helps distinguish drug effects from food effects — it should be time-limited and followed by structured reintroduction, ideally with a dietitian.

Soluble fibre is the exception to "eat less of everything". It adds form to loose stools and softens hard ones. Options include oats, psyllium and pectin — our citrus pectin powder is a gentle starting point, and the comparison of psyllium versus inulin is useful because inulin-type fibres can worsen bloating in the short term. Build up gradually — see how to increase fibre without bloating and our list of high-fibre foods in the UK.

Consider a multi-strain probiotic

This is the area where the evidence has genuinely moved. The ProGasMet trial — a randomised, double-blind, placebo-controlled crossover study of 37 people with type 2 diabetes and established metformin intolerance, published in Biomedicine & Pharmacotherapy in 2023 — found that a multi-strain probiotic significantly reduced the frequency and severity of nausea and of abdominal bloating and pain, and significantly improved self-assessed tolerability of metformin.

A 2024 meta-analysis in Pharmaceuticals, covering 26 randomised controlled trials and 41,048 patients, similarly found a decreased risk of diarrhoea, bloating and constipation when probiotics were added to metformin. A separate pilot trial of prebiotic fibre in adolescents was well tolerated but too small to demonstrate symptom benefit.

This is not a licensed treatment and it will not work for everyone, but it is a low-risk adjunct with reasonable supporting data. If you want to try one, our guides to how to choose a probiotic, single versus multi-strain formulations and when to take probiotics are the place to start, and you can browse the full Welzo probiotics range. Strain-specific options with the best evidence base for loose stools include Saccharomyces boulardii and Lactobacillus rhamnosus GG. Expect to give it four to eight weeks — see how long probiotics take to work — and be aware of the possibility of transient probiotic side effects in the first fortnight.

What about berberine?

Berberine is frequently marketed as a natural alternative to metformin. It is a legitimate compound with real metabolic research behind it, but combining it with metformin is not a casual decision: both lower blood glucose, and berberine has meaningful drug interactions via cytochrome P450 enzymes. Read our comparison of berberine versus metformin and the detail on berberine interactions before considering Welzo Ultra Purity Berberine, and discuss it with your prescriber first. Berberine can also cause its own gastrointestinal upset, which may compound rather than relieve the problem.

Metformin and the gut microbiome

There is a genuine paradox here. The microbial changes metformin causes are believed to contribute to how well it works — faecal transplant experiments transferring metformin-treated microbiota into germ-free mice improved glucose tolerance. Yet the same shifts appear to drive the early symptoms.

One consistent finding is an increase in Akkermansia muciniphila, a mucin-degrading species associated with a healthier metabolic profile and a more robust gut barrier function. If you want to understand this organism and where supplementation does and does not have evidence, see our guides to Akkermansia versus conventional probiotics and pasteurised Akkermansia, or the Welzo Akkermansia product page.

The broader principle is that a diverse, well-fed microbiome tends to absorb perturbation better than a depleted one. Practical levers include eating 30 different plants a week, adding prebiotic foods and fermented foods, and reducing ultra-processed food intake. This also matters for glycaemic control in its own right — see gut health and blood sugar.

Vitamin B12: the side effect people miss

In June 2022 the MHRA issued a Drug Safety Update reclassifying low vitamin B12 as a common side effect of metformin — affecting up to 1 in 10 people — rather than the rarity it had previously been considered. Risk rises with higher doses and longer duration, and the product information for all metformin-containing medicines was updated accordingly.

The MHRA advises checking B12 levels in people with symptoms suggestive of deficiency and monitoring those with risk factors. Symptoms include unusual fatigue, muscle weakness, a sore or red tongue, mouth ulcers, pins and needles, vision changes, and pale or yellowish skin.

This matters practically because B12 deficiency symptoms overlap with both diabetes and general tiredness, so they are easily attributed elsewhere. A retrospective analysis of 148,000 primary care records published in BMC Primary Care in 2025 found that testing rates in metformin users rose only modestly after the guidance — from 34.5% to 38.2% — meaning most people on metformin have still never had a B12 check. If you have been on metformin for several years, it is reasonable to ask. Our overview of the gut health blood test explains what related markers can and cannot tell you.

When it isn't the metformin

Attributing every gut symptom to the drug is a common trap — as the six-year IBS misdiagnosis case illustrates. Conditions that mimic or coexist with metformin intolerance include:

• Coeliac disease — around three to six times more common in people with diabetes. See coeliac testing in the UK and coeliac versus gluten intolerance.
• Small intestinal bacterial overgrowth — more common in diabetes and can be aggravated by altered motility. See SIBO in the UK and SIBO testing.
• Bile acid malabsorption — treatable with bile acid sequestrants; see bile acid malabsorption.
• Diabetic gastroparesis — delayed stomach emptying causing nausea and early fullness; see gastroparesis.
• Helicobacter pylori infection — one study found H. pylori infection measurably reduced metformin tolerance. See H. pylori and H. pylori testing.
• Exocrine pancreatic insufficiency, lactose intolerance and IBS — see lactose intolerance.

If symptoms are persistent, a faecal calprotectin test, coeliac serology and a stool test are reasonable next steps to discuss with your GP. Some people also find a gut microbiome test useful for context, though it is not diagnostic.

Red flags: when to contact a GP or NHS 111

Most metformin stomach side effects are a nuisance rather than a danger. These are not:

• Severe diarrhoea or vomiting causing dehydration — passing much less urine, or dark, strong-smelling urine
• Blood in the stool, or black tarry stools
• Unintentional weight loss
• A change in bowel habit lasting more than three weeks, particularly if you are over 50
• Severe abdominal pain
• New symptoms months or years into stable treatment

Seek urgent medical help (999 or A&E) if you develop a combination of severe tiredness and general unwellness, fast or shallow breathing, feeling cold, muscle cramps and a slow heartbeat. These can indicate lactic acidosis — a very rare but serious complication, estimated at roughly 19 cases per 100,000 patient-years, and far more likely if you are dehydrated or have reduced kidney function.

Critically, metformin should be paused during acute illness with vomiting, diarrhoea or fever — the NHS "sick day rules". Ask your diabetes team for a written copy of yours. Our guides to recovering from a stomach bug and bowel cancer screening in the UK cover related territory.

A practical four-week plan

Week 1: fix the basics

Move every dose to the middle or end of a substantial meal. Keep a simple daily log: dose, time, meal, and stool form using the Bristol chart. Cut alcohol and very high-fat meals temporarily. Hydrate deliberately.

Week 2: reduce the background noise

Trim obvious dietary triggers — sugar alcohols, large legume portions, excess caffeine. Book a free pharmacy medicines review to check for OCT1-inhibiting drugs and unnecessary PPIs. Start soluble fibre at a low dose if stools are loose or hard.

Week 3: escalate the conversation

If symptoms persist, contact your GP or diabetes nurse. Bring your log. Ask specifically about modified-release metformin, a slower titration, and a vitamin B12 check. Take the NICE recommendation with you if helpful.

Week 4: targeted gut support

Consider adding a multi-strain probiotic and give it a proper trial of at least four to eight weeks. Continue building dietary diversity. If symptoms are unchanged by week eight to twelve, push for investigation of the alternative diagnoses above rather than accepting them as unavoidable.

Frequently asked questions

How long do metformin stomach side effects last?

For most people, two to four weeks. Symptoms typically peak in the first fortnight after starting and after each dose increase, then settle as the gut adapts. If they persist beyond eight to twelve weeks on a stable dose, that is not normal adaptation and warrants review with your prescriber.

Does metformin diarrhoea ever go away?

Usually, yes. Diarrhoea is the most common metformin side effect, affecting around 7% of users in pooled real-world data, and it generally resolves within weeks. For those in whom it does not, switching to modified-release metformin resolves it for many. A minority have persistent diarrhoea that only settles on stopping the drug — which should always be a decision made with your GP, not unilaterally.

Should I take metformin with food or on an empty stomach?

Always with food, or immediately after. NHS guidance is explicit that taking metformin with food reduces nausea. A full meal slows gastric emptying and reduces the concentration of drug hitting the intestinal lining at once. Never take it on an empty stomach if you are experiencing side effects.

Is modified-release metformin better for the stomach?

The evidence says yes. Pooled analysis shows significantly lower rates of bloating, abdominal pain, constipation and vomiting with extended-release formulations. In February 2026, NICE updated its guidance to recommend modified-release metformin as the first-choice formulation, citing reductions in gastrointestinal adverse events and better adherence.

Why does metformin cause diarrhoea?

Several mechanisms operate together: metformin concentrates in the intestinal wall at levels far above those in blood; it triggers serotonin release from the duodenum; it reduces bile salt reabsorption in the ileum so bile acids spill into the colon; it increases osmotic load; and it reshapes the gut microbiome. This is also why the drug works partly in the gut rather than only in the bloodstream.

Can probiotics help with metformin side effects?

There is reasonable evidence that they can. The randomised, placebo-controlled ProGasMet crossover trial found a multi-strain probiotic significantly reduced nausea and abdominal bloating and pain, and improved self-assessed metformin tolerability, in people with established intolerance. A 2024 meta-analysis of 26 randomised trials found reduced risk of diarrhoea, bloating and constipation. It is an adjunct, not a replacement for the formulation and titration changes above.

Does metformin cause bloating and wind?

Yes — bloating affects around 6% of users in pooled data, second only to diarrhoea. It is driven largely by microbiome shifts and fermentation of substrate reaching the colon. It tends to be more prominent with standard-release formulations and typically improves within four to six weeks.

Should I take vitamin B12 with metformin?

Do not self-prescribe; ask for a blood test first. The MHRA reclassified low vitamin B12 as a common side effect of metformin in 2022, affecting up to 1 in 10 people, with risk rising with higher doses and longer treatment. Current advice is to check levels in people with symptoms and monitor those with risk factors. If your level is low, your GP will advise on the appropriate form and dose.

Can I stop metformin because of stomach side effects?

Not without medical advice. Metformin protects against the long-term complications of diabetes, and stopping it abruptly leaves that risk unmanaged. Almost every case of intolerance has options short of stopping — food timing, slower titration, modified-release formulations, medicines review, and gut support. If none work, your prescriber has alternative medicines available.

What can I take for metformin stomach pain?

Address the cause rather than masking it: take doses with a full meal, ask about slowing the titration, and ask about modified-release. Do not start anti-diarrhoeal or anti-sickness medicines without speaking to a pharmacist or doctor, as the NHS specifically advises against this while on metformin. Avoid regular ibuprofen and other NSAIDs for the pain — see our guide to ibuprofen and stomach damage.

References

1. NHS. Side effects of metformin. NHS medicines information.
2. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management (NG28) — Initial medicines. Last updated 18 February 2026.
3. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management (NG28) — Recommendations.
4. Medicines and Healthcare products Regulatory Agency. Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk. Drug Safety Update, June 2022.
5. Nabrdalik K, Hendel M, Irlik K, et al. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies. BMC Endocrine Disorders. 2024;24:206.
6. Nabrdalik K, Skonieczna-Żydecka K, Irlik K, et al. Gastrointestinal adverse events of metformin treatment: a systematic review, meta-analysis and meta-regression of randomized controlled trials. Frontiers in Endocrinology. 2022;13:975912.
7. McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59(3):426–435.
8. Wu H, Esteve E, Tremaroli V, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nature Medicine. 2017;23:850–858.
9. Forslund K, Hildebrand F, Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262–266.
10. Dujic T, Zhou K, Donnelly LA, et al. Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study. Diabetes. 2015;64(5):1786–1793.
11. Nabrdalik K, Drożdż K, Kwiendacz H, et al. Clinical trial: probiotics in metformin intolerant patients with type 2 diabetes (ProGasMet). Biomedicine & Pharmacotherapy. 2023.
12. Palacios T, et al. Metformin-associated gastrointestinal adverse events are reduced by probiotics: a meta-analysis. Pharmaceuticals. 2024;17(7):898.
13. Bonnet F, Scheen A. Understanding and overcoming metformin gastrointestinal intolerance. Diabetes, Obesity and Metabolism. 2017;19(4):473–481.
14. Elbere I, Kalnina I, Silamikelis I, et al. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers. PLOS ONE. 2018;13(9):e0204317.
15. Chaudhary M, Midha NK, Sukhadiya P, et al. Metformin-induced chronic diarrhea misdiagnosed as irritable bowel syndrome for years. Cureus. 2024;16(3):e56828.
16. Huang Y, Sun J, Wang X, et al. Helicobacter pylori infection decreases metformin tolerance in patients with type 2 diabetes mellitus. Diabetes Technology & Therapeutics. 2015;17(2):128–133.
17. Parsonage I, Wainwright D, Barratt J. Impact of the MHRA safety update on vitamin B12 testing and coding in metformin users: a retrospective primary care analysis. BMC Primary Care. 2025.
18. Cubeddu LX, Bönisch H, Göthert M, et al. Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 2000;361(1):85–91.

About the author

Dr Zeeshan Afzal (MBBS) is a Medical Officer at Welzo. He writes and reviews Welzo's clinical content on digestive health, metabolic medicine and evidence-based supplementation, with a focus on translating UK guidance and peer-reviewed research into practical advice for patients.

Medical disclaimer

This article is for general information only and does not constitute medical advice, diagnosis or treatment. It is not a substitute for consultation with a qualified healthcare professional. Metformin is a prescription-only medicine: do not start, stop, or change your dose or formulation without speaking to your GP, diabetes nurse or pharmacist. Dietary supplements are not medicines and are not intended to diagnose, treat, cure or prevent any disease. If you are pregnant, breastfeeding, have kidney or liver disease, or take other prescribed medicines, seek individual advice before starting any supplement. In a medical emergency, call 999.